(Q37592754)

21 August 2017

1 reference

title

Clinical use of beta-adrenoceptor blockade in systemic hypertension (English)

1 reference

21 August 2017

main subject

arterial hypertension

0 references

author name string

Nadelmann J

series ordinal

1

1 reference

21 August 2017

Frishman WH

series ordinal

2

1 reference

21 August 2017

publication date

1 June 1990

1 reference

21 August 2017

1 reference

21 August 2017

volume

39

1 reference

21 August 2017

issue

6

1 reference

21 August 2017

page(s)

862-876

1 reference

Drug therapy: atenolol and timolol, two new systemic beta-adrenoceptor antagonists

21 August 2017

cites work

1 reference

12 December 2020

Drug therapy: metoprolol

1 reference

12 December 2020

Intrinsic sympathomimetic activity of?-adrenoceptor blocking agents

1 reference

12 December 2020

Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study

1 reference

12 December 2020

Nadolol: a new beta-adrenoceptor antagonist

1 reference

12 December 2020

Cardiac hypertrophy and antihypertensive therapy

1 reference

12 December 2020

Propranolol-induced hypoglycaemia and myocardial infarction

1 reference

12 December 2020

Comparison of atenolol and propranolol during insulin-induced hypoglycaemia

1 reference

12 December 2020

Left ventricular hypertrophy regression in hypertensive patients treated with metoprolol

1 reference

12 December 2020

The beta-adrenoceptor blocking drugs

1 reference

12 December 2020

Effects of intravenous propranolol and metoprolol and their interaction with isoprenaline on pulmonary function, heart rate and blood pressure in asthmatics

1 reference

12 December 2020

Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension.

1 reference

12 December 2020

Redistribution of cardiac output to the kidneys during oral nadolol administration

1 reference

12 December 2020

Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males

1 reference

12 December 2020

Beta-adrenergic blockers.

1 reference

12 December 2020

Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial

1 reference

12 December 2020

Control of the splanchnic circulation in man. Role of beta-adrenergic receptors.

1 reference

12 December 2020

Clinical experience with timolol maleate monotherapy of hypertension

1 reference

12 December 2020

The clinical pharmacology of beta-adrenoceptor-blocking drugs

1 reference

12 December 2020

Comparative hypotensive effects of acebutolol and hydrochlorothiazide in patients with mild to moderate essential hypertension: a double-blind multicenter evaluation

1 reference

12 December 2020

Acebutolol, atenolol, and propranolol and metabolic responses to acute hypoglycaemia in diabetics

1 reference

12 December 2020

Regression of left ventricular hypertrophy in hypertension: comparative effects of three different drugs.

1 reference

12 December 2020

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effects

1 reference

12 December 2020

Comparison of effects of metoprolol and propranolol on asthmatic airway obstruction

1 reference

12 December 2020

Effect of propranolol and prazosin on blood lipids. The Oslo Study

1 reference

12 December 2020

Hypertension prevalence and the status of awareness, treatment, and control in the United States. Final report of the Subcommittee on Definition and Prevalence of the 1984 Joint National Committee

1 reference

12 December 2020

Calcium entry blockade or beta-blockade in long-term management of hypertension in blacks

1 reference

12 December 2020

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 1. Pharmacodynamic and pharmacokinetic properties

1 reference

12 December 2020

Antihypertensive beta blocking action as related to renin and age: A pharmacologic tool to identify pathogenetic mechanisms in essential hypertension

1 reference

12 December 2020

Cardiovascular pharmacology of propranolol in man

1 reference

12 December 2020

Comparison of intravenous AH 5158 (ibidomide) and propranolol in asthma

1 reference

12 December 2020

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 8. Self-poisoning with beta-adrenoceptor blocking agents: recognition and management

1 reference

12 December 2020

β-Adrenergic blockade and atrio-ventricular conduction impairment

1 reference

12 December 2020

Effects of propranolol on blood lipids and lipoproteins in myocardial infarction

1 reference

12 December 2020

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 6. A comparison of pindolol and propranolol in treatment of patients with angina pectoris. The role of intrinsic sympathomimetic activity

1 reference

12 December 2020

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 3. Comparative clinical experience and new therapeutic applications

1 reference

12 December 2020

The emerging problem of plasma lipid changes during antihypertensive therapy

1 reference

12 December 2020

Effects of labetalol on left ventricular mass and function in hypertension — An assessment by serial echocardiography

1 reference

12 December 2020

The Norwegian Multicenter Study of Timolol after Myocardial Infarction

1 reference

12 December 2020

Cerebral metabolic changes during treatment of subacute cerebral infarction by alpha and beta adrenergic blockade with phenoxybenzamine and propranolol

1 reference

12 December 2020

Intravenous beta-blockade in coronary heart disease: is cardioselectivity or intrinsic sympathomimetic activity hemodynamically useful?

1 reference

12 December 2020

The disposition of propranolol. I. Elimination during oral absorption in man

1 reference

12 December 2020

Effect of acebutolol on left ventricular hemodynamics and anatomy in systemic hypertension

1 reference

12 December 2020

Monotherapy with labetalol for hypertensive patients with normal and impaired renal function

1 reference

12 December 2020

Monotherapy with labetalol compared with propranolol. Differential effects by race

1 reference

12 December 2020

The clinical importance of cardioselectivity and lipophilicity in beta blockers.

1 reference

12 December 2020

Hypertension: which beta-blocker?

1 reference

12 December 2020

A novel therapeutic approach for reversal of left ventricular hypertrophy and blood pressure control in hypertensive patients treated with alpha-methyldopa or propranolol

1 reference

12 December 2020

The effects of antihypertensive agents on serum lipids and lipoproteins

1 reference

12 December 2020

Clinical Pharmacokinetics of β-Adrenoreceptor Blocking Drugs

1 reference

12 December 2020

Cardiac responses to increased afterload. State-of-the-art review

1 reference

12 December 2020

A long-term prevention study with oxprenolol in coronary heart disease

1 reference

12 December 2020

beta-Adrenoceptor antagonists: new drugs and new indications

1 reference

12 December 2020

Beta-blockers and the kidney

1 reference

12 December 2020

Comparative chronotropic activity of beta-adrenoceptive antagonists

1 reference

12 December 2020

Assessment of left-ventricular mass and its response to antihypertensive treatment

1 reference

12 December 2020

Drug therapy. Pindolol: a new beta-adrenoceptor antagonist with partial agonist activity

1 reference

12 December 2020

A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results

1 reference

12 December 2020

The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials

1 reference

12 December 2020

Mechanism of Increased Sodium Reabsorption during Propranolol Administration

1 reference

12 December 2020

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 7. New horizons in beta-adrenoceptor blockade therapy: Labetalol

1 reference

12 December 2020

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a β-adrenoreceptor blocker

1 reference

12 December 2020

Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 5. Pindolol (LB-46) therapy for supraventricular arrhythmia: a viable alternative to propranolol in patients with bronchospasm

1 reference

12 December 2020

Regression of myocardial hypertrophy and influence of adrenergic system

1 reference

12 December 2020

Reduced β-adrenoceptor sensitivity in the elderly

1 reference

12 December 2020

Hypoglycaemia precipitated by propranolol

1 reference

12 December 2020

The effect of treatment on mortality in "mild" hypertension: results of the hypertension detection and follow-up program

1 reference

12 December 2020

The effect of pindolol on the two years mortality after complicated myocardial infarction

1 reference

12 December 2020

The effect of ageing on the hepatic clearance of propranolol

1 reference

12 December 2020

1 reference

12 December 2020

A comparison of verapamil and propranolol for the initial treatment of hypertension. Racial differences in response

1 reference

12 December 2020

Effect of Age and Sex on Human Drug Metabolism

1 reference

12 December 2020

Antihypertensive drugs and blood lipids: the Oslo study

1 reference

12 December 2020

Beta-adrenergic receptor blocking drugs in cardiac arrhythmias

1 reference

12 December 2020

10.2165/00003495-199039060-00005

Identifiers

DOI

1 reference

Dimensions Publication ID

21 August 2017

1043763990

0 references

1 reference